Home | Welcome to Contract Pharma   
Last Updated Friday, April 25 2014
Print RSS Feed

Breaking News

November 26, 2013
To develop abuse-deterrent oral hydrocodone opioid candidates  Read More »
November 26, 2013
Tripathy to oversee management of clinical and commercial growth  Read More »
November 26, 2013
To develop Anthracycline chemotherapy benefit test  Read More »
November 26, 2013
Keesee to lead site functions for clinical packaging and distribution facilities  Read More »
November 25, 2013
FDA approves Bayer/Onyx, J&J and GSK drugs  Read More »
November 25, 2013
Will begin Phase 1/2 bladder cancer trial  Read More »
November 25, 2013
Aims to develop one-month treatment therapy  Read More »
November 25, 2013
Offers expanded capabilities at Israel research center  Read More »
November 25, 2013
Dr. Kellen joins the executive management team  Read More »
November 25, 2013
To develop Dynamix’ SYK/JAK product through proof-of-concept  Read More »
November 25, 2013
Dick will be responsible for all manufacturing operations  Read More »
November 25, 2013
Creates expansive manufacturer and distributor of health products  Read More »
Gil Roth
November 22, 2013
Bayer, Biogen Idec, DelMar, Janssen, J&J, Pfizer, Regeneron, Sanofi, Threshold  Read More »
November 22, 2013
Aronstein brings 30 years of clinical, academic, and industry experience  Read More »
November 22, 2013
Domi to lead HIV vaccines efforts  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On